Related Experiment Video
Updated: Mar 1, 2026

05:21
Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
948
Bioassay for tumor necrosis factors-alpha and -beta
1Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Molecular Biotechnology
|September 15, 2000
Abstract:
Tumor necrosis factor (TNF) is a central cytokine in the pathogenesis of septic shock and other inflammatory states. Assay by immunoassay is convenient, but, because of circulating soluble receptors, does not accurately reflect biological activity of the cytokine. This article describes how to perform a bioassay for TNF, using its cytopathic effect on the murine cell line L929. By suitable manipulation, the assay can determine the two different forms of TNF, alpha and beta.

